Advertisement

The Japanese perspective on registries and a review of clinical trial process in Japan

  • Hisako Matsuba
  • Takahiro Kiuchi
  • Kiichiro Tsutani
  • Eiji Uchida
  • Yasuo Ohashi

Keywords

Clinical Trial Registry Clinical Trial Registration Medical Journal Editor INDICE Service Pharmaceutical Affair 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kiuchi T, Igarashi T (2004) UMIN — Current status and future perspectives. Medinfo 11: 1068–1072PubMedGoogle Scholar
  2. 2.
    University Hospital Medical Information Network. UMIN Clinical Trial Registry. Available at http://www.umin.ac.jp/ctr/index.htm (accessed 17 February 2006)Google Scholar
  3. 3.
    Standards for the Conduct of Clinical Trials on Drugs. The Ministry of Health and Welfare ordinance No. 28; March 27, 1997Google Scholar
  4. 4.
    Standards for the Conduct of Clinical Trials on Medical Devices. The Ministry of Health, Labour and Welfare ordinance No. 36; March 23, 2005Google Scholar
  5. 5.
    International Conference on Harmonization. ICH Harmonized Tripartite Guideline. Guideline for Good Clinical Practice. 1 May 1996Google Scholar
  6. 6.
    Ethical Guidelines for Clinical Studies. The Ministry of Health, Labour and Welfare announcement No. 255; July 16, 2003; revised by The Ministry of Health, Labour and Welfare announcement No. 459; December 28, 2004Google Scholar
  7. 7.
    Ethical Guidelines for Epidemiological Studies. The Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare announcement No. 2, June 17, 2002, revised by The Ministry of Education, Culture, Sports, Science and Technology and The Ministry of Health, Labour and Welfare announcement No. 1, December 28, 2004Google Scholar
  8. 8.
    Guidelines for Clinical Studies on Gene Therapies. The Ministry of Education, Culture, Sports, Science and Technology, and The Ministry of Health, Labour and Welfare announcement No. 1, March 27, 2002, revised by The Ministry of Education, Culture, Sports, Science and Technology and The Ministry of Health, Labour and Welfare announcement No. 2, December 28, 2004Google Scholar
  9. 9.
    The Pharmaceutical Affairs Law. Law No. 145, August 10, 1960Google Scholar
  10. 10.
    The Enforcement Regulation of Pharmaceutical Affairs Law. The Ministry of Health and Welfare ordinance No. 1, February 1, 1961Google Scholar
  11. 11.
    Outline of Manufacturing Approval for Pharmaceutical Products. The Pharmaceutical Affairs Bureau notification No 645, September 13, 1967Google Scholar
  12. 12.
    Standards for the Conduct of Clinical Trials on Drugs. The Pharmaceutical Affairs Bureau notification No. 874, October 2, 1989Google Scholar
  13. 13.
    The Ministry of Health, Labour and Welfare. Yakumu Koho. Tokyo, Yakumu Koho Sha (in Japanese)Google Scholar
  14. 14.
    Tsutani K (2003) Evidence wo Shiraberu — Sisutematikku Rebyu no Genjo (Examine evidences — present situation of systematic review). Rinsho Yakuri (Jpn J Clin Pharmacol Ther) 34: 210–216 (in JapanesGoogle Scholar
  15. 15.
    Tsutani K, Kaneko Y, Nakayama T et al (2002) Nihon de wa Maitsuki Yaku 70 Pen no RCT ga Houkoku Sarete Iru (70 randomized clinical trials are estimated to be reported monthly in Japan). Rinsho Yakuri (Jpn J Clin Pharmacol Ther) 33: 273S–274S (in Japanese)Google Scholar
  16. 16.
    Japan Hand Search & Electronic Search Society. Available at: http://jhes.umin.ac.jp (Accessed 10 March 2006)Google Scholar
  17. 17.
    Easterbrook PJ, Berline JA, Gopalan R, Matthews DR (1991) Publication bias in clinical research. Lancet 337: 867–872PubMedCrossRefGoogle Scholar
  18. 18.
    Stem JM, Simes RJ (1997) Publication bias: evidence of delayed publication in a cohort study of clinical research projects. Br Med J 315: 640–645Google Scholar
  19. 19.
    Decullier E, Lheritier V, Chapuis F (2005) Fate of biomedical research protocols and publication bias in France: retrospective cohort study. Br Med J 331: 19–22CrossRefGoogle Scholar
  20. 20.
    Pharmaceuticals and Medical devises Agency. Available at www.info.pmda.go.jp (Accessed 8 February 2006)Google Scholar
  21. 21.
    New Drug Application. Pharmaceutical and Food Safety Bureau notification No. 481, April 8, 1999Google Scholar
  22. 22.
    Narukawa M (2000) Shinyaku no Shonin Shinsa Katei no Tomeika to “Shinyaku Shonin Johoshu” ni Tsuite (Transparency of new drug review process and “New Drug Approval Package” by MHW, Japan. Rinsho Hyoka (Clin Eval) 27: 519–527 (in Japanese)Google Scholar
  23. 23.
    Sunaga M (2005) Publisher no Tachiba kara (From publisher’s standpoint). Rinsho Iyaku (J Clin Ther Med) 1138: 114S (in Japanese)Google Scholar
  24. 24.
    Beppu H (1999) Japan’s loss of leadership role in access to drug data. Lancet 353: 1992PubMedCrossRefGoogle Scholar
  25. 25.
    Pharmaceutical Research and Manufacturers of America. Joint position on the disclosure of clinical trial information via clinical trial registries and databases. Available at: www.phrma.org/publications/policy//admin/2005-01-06.1113.PDF (Accessed 8 February 2006)Google Scholar
  26. 26.
    Kaneko Y, Tsutani K, Nakayama T et al (2002) 2000 Nen ni Nihon de Hokoku Sareta RCT no Naiyo (Analysis of contents of randomized controlled trials reported in Japan in 2000). Rinsho Yakuri (Jpn J Clin Pharmacol Ther) 33: 323S–324S (in Japanese)Google Scholar
  27. 27.
    Tsutani K, Hirose M, Kurihara C et al. Handsearch and electronic search projects in Japan. 8th International Cochrane Colloquium. 25–29 October 2000, Cap Town, South Africa (page 218)Google Scholar
  28. 28.
    DeAngeles CD, Drazen JM, Frizelle FA et al (2004) Clinical Trial registration; a statement from the International Committee of Medical Journal Editors. JAMA 292: 1363–1364CrossRefGoogle Scholar
  29. 29.
    Translational Research Informatics Center. Center Information Japan. Available at: http://cancerinfo.tri-kobe.org/clinicaltrials/index.html (Accessed 17 February 2006)Google Scholar
  30. 30.
    Japan Clinical Oncology Group (JCOG). Research Groups. Available at: http://www.jcog.jp/STUDY_GROUP/fra_grouptop.htm (Accessed 17 February 2006)Google Scholar
  31. 31.
    Japan Pharmaceutical Information Center. Clinical Trials Information. Available at: http://www.clinicaltrials.jp/user/cte_main.jsp (Accessed 17 February 2006)Google Scholar
  32. 32.
    Center for Clinical Trials, Japan Medical Association. Clinical Trial Registration. Available at: http://dbcentre2.jmacct.med.or.jp/ctrialr (Accessed 17 February 2006)Google Scholar
  33. 33.
    World Health Organization. International Clinical Trials Registry Platform. Available at: http://www.who.int/ictrp/en (Accessed 17 February 2006)Google Scholar
  34. 34.
    Gulmezoglu AM, Pang T, Horton R, Dickersin K (2005) WHO facilitates international standards for clinical trial registration. Lancet 365: 1829–1831PubMedCrossRefGoogle Scholar
  35. 35.
    Chalmers I (1990) Underreporting research is scientific misconduct. JAMA 263: 1405–1408PubMedCrossRefGoogle Scholar
  36. 36.
    Fukushima M (1995) Clinical trials in Japan. Nat Med 1: 12–13PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2006

Authors and Affiliations

  • Hisako Matsuba
    • 1
  • Takahiro Kiuchi
    • 2
  • Kiichiro Tsutani
    • 3
  • Eiji Uchida
    • 4
  • Yasuo Ohashi
    • 5
  1. 1.EPS Co., Ltd.TokyoJapan
  2. 2.University Hospital Medical Information NetworkThe University of TokyoTokyoJapan
  3. 3.Graduate School of Pharmaceutical SciencesThe University of TokyoTokyoJapan
  4. 4.Second Department of Pharmacology, School of MedicineShowa UniversityTokyoJapan
  5. 5.School of Health Sciences and NursingThe University of TokyoTokyoJapan

Personalised recommendations